BlendsHealing
BPC-157 10mg + TB-500 10mg
Peptide blend · BPC-157 + Thymosin Beta-4 · Synthetic
FDA · CATEGORY 2 (2023)
Half-life
~5 hours
Short
minsdays
Route
SubQ injection
Evidence
Preclinical only
Risk
Standard
Reference only — not an endorsement.
Overview
Known for
Mechanism
Key facts
Format
Lyophilized powder
Mechanism targets
Classification
Secondary
Supply & nature
Natural / Topping UpNatural
FDA category
Category 2 (2023)
Evidence & standing
Evidence base
Preclinical only
Risk level
Standard
Best studies
3 references
Dosage & protocol
Typical dose
250-500mcg
Cycle
4 weeks on / 2 weeks off
Onset
5 days first effects
Full effect
42 days
Half-life
~4h / ~4-6h
BPC: ~4hrs | TB-500: ~4-6hrs
Protocol
Time to effects
Recommended vial
Reference figures only
Dosing reflects published laboratory protocols and is not guidance for use in any living subject.
Safety
Reversibility
Fully Reversible
Side effects
Interactions
Handle with research caution
Storage & handling
Lyophilised
12–24 months
2–8°C
Reconstituted
4–6 weeks
2–8°C
Videos & talks
Independent educational content from researchers, clinicians and science communicators — not affiliated with Pepnerd.
Educational resources only. Videos are independent third-party content. Pepnerd is not affiliated with these creators and does not endorse or make claims based on their content. All products are for in-vitro research.





